Drugs.com Newsletter Vol 91 - March 2012 RSS News Feeds: http://www.drugs.com/rss.html You received this email because you are subscribed to updates from Drugs.com Change your notification settings or unsubscribe here: http://www.drugs.com/my_subscriptions.php?email=%PERS_EMAIL%&pid=%PERS_ID% FEATURED NEWS ------------- Monthly News Round Up - March 2012 March 2012 - Omontys Approved For Dialysis Patients with Anemia Due to Chronic Kidney Disease The U.S Read more: http://www.drugs.com/news/monthly-news-round-up-march-2012-37324.html NEW DRUG APPROVALS ------------------ The following drugs have recently been approved by the FDA. Omontys (peginesatide) Injection http://www.drugs.com/omontys.html Date of Approval: March 27, 2012 Treatment for: Anemia Associated with Chronic Renal Failure Omontys Drug Information: http://www.drugs.com/omontys.html Press Release: http://www.drugs.com/newdrugs/affymax-takeda-announce-fda-approval-omontys-peginesatide-anemia-due-chronic-kidney-ckd-adult-3156.html QNASL (beclomethasone dipropionate) Nasal Aerosol http://www.drugs.com/qnasl.html Date of Approval: March 23, 2012 Treatment for: Allergic Rhinitis QNASL Drug Information: http://www.drugs.com/qnasl.html Press Release: http://www.drugs.com/newdrugs/teva-announces-fda-approval-qnasl-beclomethasone-dipropionate-new-nonaqueous-nasal-aerosol-allergic-3154.html Binosto (alendronate) Effervescent Tablets http://www.drugs.com/binosto.html Date of Approval: March 12, 2012 Treatment for: Osteoporosis Binosto Drug Information: http://www.drugs.com/binosto.html Press Release: http://www.drugs.com/newdrugs/fda-approves-binosto-first-only-effervescent-osteoporosis-buffered-solution-3149.html Surfaxin (lucinactant) Intratracheal Suspension http://www.drugs.com/surfaxin.html Date of Approval: March 6, 2012 Treatment for: Respiratory Distress Syndrome Surfaxin Drug Information: http://www.drugs.com/surfaxin.html Press Release: http://www.drugs.com/newdrugs/discovery-labs-announces-fda-approval-surfaxin-lucinactant-prevention-respiratory-distress-syndrome-3144.html Ultresa (pancrelipase) Delayed Release Capsules http://www.drugs.com/ultresa.html Date of Approval: March 1, 2012 Treatment for: Pancreatic Exocrine Dysfunction Ultresa Drug Information: http://www.drugs.com/ultresa.html Press Release: http://www.drugs.com/newdrugs/aptalis-pharma-announces-fda-approval-ultresa-pancrelipase-delayed-release-capsules-3119.html Viokace (pancrelipase) Tablets http://www.drugs.com/viokace.html Date of Approval: March 1, 2012 Treatment for: Pancreatic Exocrine Dysfunction Viokace Drug Information: http://www.drugs.com/viokace.html Press Release: http://www.drugs.com/newdrugs/aptalis-pharma-announces-fda-approval-viokace-pancrelipase-3120.html New Indications and Dosage Forms -------------------------------- Drugs that have gained FDA approval for the treatment of additional diseases/conditions or new dosage forms/regimens. FluMist (Influenza Virus Vaccine, Live, Intranasal) http://www.drugs.com/flumist.html New Formulation Approved: March 1, 2012 Now Approved: FluMist Quadrivalent FluMist Drug Information: http://www.drugs.com/flumist.html Press Release: http://www.drugs.com/newdrugs/fda-approves-flumist-quadrivalent-vaccine-prevent-seasonal-influenza-3117.html Natazia (dienogest and estradiol valerate) http://www.drugs.com/natazia.html New Indication Approved: March 14, 2012 Now Approved for: Heavy Menstrual Bleeding Natazia Drug Information: http://www.drugs.com/natazia.html Press Release: http://www.drugs.com/newdrugs/u-s-fda-approves-first-only-oral-contraceptive-demonstrated-heavy-menstrual-bleeding-hmb-3150.html Intelence (etravirine) Tablets http://www.drugs.com/intelence.html Patient Population Altered: March 26, 2012 Now Approved for: Pediatric Patients Intelence Drug Information: http://www.drugs.com/intelence.html Press Release: http://www.drugs.com/newdrugs/fda-approves-intelence-etravirine-experienced-pediatric-patients-hiv-1-following-priority-review-3155.html First-Time Generic Approvals ---------------------------- First Time Generics are those drug products that have never been approved before as generic drug products and are new generic products to the marketplace.Cisatracurium Besylate Injection 2 mg (base)/mL; packaged in 20 mg (base)/10 mL multiple-dose vials Approved: February 3, 2012 - Sandoz Inc. Generic for: Nimbex InjectionCisatracurium Besylate Injection (Preservative Free) 10 mg (base)/mL packaged in 200 mg (base)/20 mL; and 2 mg (base)/mL packaged in 100 mg (base)/5 mL single-dose vials Approved: February 3, 2012 - Sandoz Inc. Generic for: Nimbex InjectionTizanidine Hydrochloride Capsules 2 mg (base), 4 mg (base) and 6 mg (base) Approved: February 3, 2012 - Apotex Inc. Generic for: Zanaflex CapsulesDoxycycline Hyclate Delayed-Release Tablets USP, 150 mg (base) Approved: February 8, 2012 - Mylan Pharmaceuticals Inc. Generic for: Doryx Delayed-Release Tablets Read more: http://www.drugs.com/generic-approvals.html OTHER DRUG NEWS --------------- Warm Weather Triggers Early Allergy Season http://www.drugs.com/news/warm-weather-triggers-early-allergy-season-37306.html First Bedside Gene Test Shows Promise http://www.drugs.com/news/first-bedside-gene-test-shows-promise-37287.html Two Experimental Drugs Could Improve Psoriasis Treatment http://www.drugs.com/news/two-experimental-could-improve-psoriasis-37270.html New Injection Might Lower Tough-to-Treat Cholesterol http://www.drugs.com/news/new-might-lower-tough-cholesterol-37220.html Statin Alternative Looks Promising in Early Trials http://www.drugs.com/news/statin-alternative-looks-promising-early-trials-37130.html Antibiotics Useless for Most Sinus Infections, Experts Say http://www.drugs.com/news/antibiotics-useless-most-sinus-infections-experts-say-37124.html More Evidence Shows That Daily Aspirin Might Combat Cancer http://www.drugs.com/news/more-evidence-shows-daily-aspirin-might-combat-cancer-37106.html Ibuprofen May Ward Off Altitude Sickness http://www.drugs.com/news/ibuprofen-may-ward-off-altitude-sickness-37093.html New Type 2 Diabetes Drug Helps Lower Blood Sugar: Study http://www.drugs.com/news/new-type-2-diabetes-helps-lower-blood-sugar-study-37079.html New Gel Treats Precancerous Skin Condition in Days: Study http://www.drugs.com/news/new-gel-treats-precancerous-skin-condition-days-study-36985.html Experimental Pill May Ease Multiple Sclerosis Disability http://www.drugs.com/news/experimental-pill-may-ease-multiple-sclerosis-disability-36982.html Seniors' Long-Term Use of Strong Painkillers a Concern http://www.drugs.com/news/seniors-long-term-strong-painkillers-concern-36927.html Woman's Recovery From Advanced Melanoma Could Help Guide Research http://www.drugs.com/news/woman-s-recovery-advanced-melanoma-could-help-guide-research-36858.html Prescription Meds Can Put on Unwanted Pounds http://www.drugs.com/news/meds-can-put-unwanted-pounds-36772.html More news headlines: http://www.drugs.com/news.html FDA MEDWATCH ALERTS -------------------Drug Safety Communication: Celexa (citalopram hydrobromide) - Revised Recommendations, Potential Risk of Abnormal Heart Rhythms http://www.drugs.com/fda/celexa-citalopram-hydrobromide-safety-communication-revised-recommendations-potential-risk-abnormal-13107.html Recall: Argatroban Injection 50 mg/50 mL (1 mg/mL) - Potential for Visible Particulates http://www.drugs.com/fda/argatroban-50-mg-50-ml-1-mg-ml-recall-potential-visible-particulates-13106.html Brilliant Blue G Compounded by Franck's: Recall of Unapproved Drug - Ongoing Investigation of Fungal Endophthalmitis Cases http://www.drugs.com/fda/brilliant-blue-g-compounded-franck-s-recall-unapproved-ongoing-investigation-fungal-endophthalmitis-13105.html Skin Creams, Soaps and Lotions Marketed as Skin Lighteners and Anti-aging Treatments: May Contain the Toxic Metal, Mercury http://www.drugs.com/fda/skin-creams-soaps-lotions-marketed-skin-lighteners-anti-aging-treatments-may-contain-toxic-metal-13102.html Drug Safety Communication: Statins and HIV or Hepatitis C Drugs - Interaction Increases Risk of Muscle Injury http://www.drugs.com/fda/statins-hiv-hepatitis-c-safety-communication-increases-risk-muscle-injury-13098.html More FDA Medwatch Alerts: http://www.drugs.com/fda_alerts.html TOOLS & HELPFUL LINKS --------------------- Community Discussion Forums - We welcome you to share your experiences. http://www.drugs.com/forum/ Medical Encyclopedia - Use this feature to find information on diseases, symptoms, injuries, medical tests and surgical procedures. http://www.drugs.com/enc/ Browse by Medical Condition - Use this feature to find drugs or medication related to a condition or therapeutic group. http://www.drugs.com/medical_conditions.html Pill Identifier - The Pill Identifier enables a search for unidentified pills by imprint code or shape/color. http://www.drugs.com/pill_identification.html Drug Interactions Checker - Increasingly popular as more healthcare professionals and consumers make the effort to seek detailed information on drug-drug and drug-food interactions. http://www.drugs.com/drug_interactions.html New Drugs - All the latest information on FDA Approvals and recent additions to the database. http://www.drugs.com/newdrugs.html News & Articles - Roundup of recent drug-related news and press releases. also latest news from FDA Medwatch service including timely publication of recalls, withdrawals, warnings, and label/packaging changes. http://www.drugs.com/news.html ABOUT THIS NEWSLETTER --------------------- Drugs.com is not affiliated with any pharmaceutical company. We are dedicated to providing consumers and health professionals with objective information about prescription-medication discoveries and side effects. This information is not intended to be medical advice. You should contact your physician before making any changes to your health care. Drugs.com is not responsible for content provided by third-party websites. Your Feedback We always appreciate feedback so if you wish to give us your comments/ praise/ rebuke please Contact Us here: http://www.drugs.com/support/contact.html Thanks so much for your continued support! The Editorial Team Drugs.com Your Privacy - Any personal information you provide to us will only be used to notify you of offers, information and activities. We'll hold the information about you securely and will not disclose it except for this purpose, or when required by law. Copyright © 2012 Drugs.com. All Rights Reserved. You received this email because you are subscribed to updates from Drugs.com Change your notification settings or unsubscribe here: http://www.drugs.com/my_subscriptions.php?email=%PERS_EMAIL%&pid=%PERS_ID%